Reduced-Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor-Reference-Cited by-同舟云学术

Reduced-Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor

Published:2008-03 Issue:3 Volume:14 Page:282-289
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Majhail Navneet S.,Brunstein Claudio G.,Tomblyn Marcie,Thomas Avis J.,Miller Jeffrey S.,Arora Mukta,Kaufman Dan S.,Burns Linda J.,Slungaard Arne,McGlave Philip B.,Wagner John E.,Weisdorf Daniel J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning;Baron;J Clin Oncol,2005

2. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies;Maris;Blood,2003

3. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program;Giralt;Biol Blood Marrow Transplant,2007

4. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors;Beatty;Hum Immunol,2000

5. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation;Dodson;Clin Transpl,1999

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Umbilical Cord Blood Transplantation;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation;Current Opinion in Hematology;2022-11-18

3. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study;Leukemia;2019-05-09

4. Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation;Blood Advances;2019-01-23

5. History and Current Status of Hematopoietic Cell Transplantation;Hematopoietic Cell Transplantation for Malignant Conditions;2019